 | Xeris Pharmaceuticals (NASDAQ:XERS) Stock Rating Lowered by BidaskClub
marketbeat.com - September 25 at 6:10 AM |
 | Xeris Pharmaceuticals (XERS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
finance.yahoo.com - October 29 at 2:05 PM |
| Is Xeris Pharmaceuticals (NASDAQ:XERS) Weighed On By Its Debt Load?
finance.yahoo.com - October 28 at 5:20 PM |
 | Xeris Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:XERS)
americanbankingnews.com - October 21 at 1:53 PM |
| Xeris Pharmaceuticals Granted Fast Track Designation by the FDA for Its Novel Concentrated Diazepam Formulation (XP-0863) For Injection
finance.yahoo.com - October 20 at 7:07 PM |
| Xeris Pharmaceuticals (NASDAQ:XERS) Trading Up 8.7%
americanbankingnews.com - October 19 at 7:04 PM |
| Shark Bites: Convergence of News and Technicals Makes Xeris Interesting
finance.yahoo.com - October 19 at 6:43 PM |
| Xeris Pharmaceuticals (NASDAQ:XERS) Shares Down 5.3%
americanbankingnews.com - October 9 at 8:01 PM |
| Xeris Pharmaceuticals (NASDAQ:XERS) Trading 5.5% Higher
americanbankingnews.com - October 8 at 8:04 PM |
| Xeris Pharmaceuticals'(NASDAQ:XERS) Share Price Is Down 31% Over The Past Year.
finance.yahoo.com - September 22 at 4:39 PM |
|
 | Thinking about buying stock in Marinus Pharmaceuticals, Fiat Chrysler, Lithium Americas, Xeris Pharmaceuticals, or Nokia?
marketwatch.com - September 15 at 10:08 AM |
| Xeris Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
finance.yahoo.com - September 8 at 9:52 AM |
 | Xeris Looks Like A High-Quality Platform Play As Gvoke Sales Increase
seekingalpha.com - August 31 at 1:14 AM |
| XERS Aug 2020 2.500 call
au.finance.yahoo.com - August 23 at 8:57 AM |
| Xeris Pharmaceuticals Appoints John Shannon President and Chief Operating Officer
finance.yahoo.com - August 20 at 8:20 PM |
| FDA warns Xeris over Gvoke ad; shares down 13%
seekingalpha.com - August 20 at 3:15 PM |
| Are Options Traders Betting on a Big Move in Xeris Pharmaceuticals (XERS) Stock?
finance.yahoo.com - August 18 at 2:12 PM |
| Xeris Pharmaceuticals (XERS) Looks Good: Stock Adds 5.1% in Session
finance.yahoo.com - August 11 at 11:29 AM |
| Xeris Pharmaceuticals, Inc. (XERS) CEO Paul Edick on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 10 at 5:23 PM |
| Xeris Pharmaceuticals, Inc. (XERS) Q2 2020 Earnings Call Transcript
finance.yahoo.com - August 10 at 5:23 PM |
| Recap: Xeris Pharmaceuticals Q2 Earnings
finance.yahoo.com - August 10 at 12:23 PM |
| Xeris Pharmaceuticals, Inc. (XERS) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 10 at 12:23 PM |
| Xeris Pharmaceuticals Reports Second Quarter 2020 Financial Results and Corporate Highlights
finance.yahoo.com - August 10 at 7:19 AM |
| Xeris Pharmaceuticals to Announce Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 10, 2020
finance.yahoo.com - August 3 at 7:00 PM |
| Xeris Pharmaceuticals Announces Additional Data From a Phase 1b Comparative Study of Its Novel Concentrated Diazepam Formulation (XP-0863) and an Expedited Clinical Path Forward
finance.yahoo.com - July 30 at 9:48 AM |
| Xeris Pharmaceuticals Announces Full Exercise of Underwriters’ Options to Purchase Additional Shares and Additional Notes
finance.yahoo.com - July 15 at 8:38 PM |
| Xeris Spikes 12% After-Hours On Soros Stake; Analyst Says Buy
finance.yahoo.com - July 12 at 8:19 AM |
| Xeris Pharma up 11% after hours on Soros stake
seekingalpha.com - July 10 at 6:59 PM |
| Hedge Funds Have Never Been This Bullish On Xeris Pharmaceuticals, Inc. (XERS)
finance.yahoo.com - July 6 at 12:53 PM |
| Xeris Pharma launches Gvoke HypoPen for hypoglycemia in U.S.
seekingalpha.com - July 1 at 9:38 AM |
|
| 2 Beaten-Up Penny Stocks That Look Set for a Rebound
finance.yahoo.com - June 30 at 6:23 PM |
| Xeris Pharmaceuticals (XERS) in Focus: Stock Moves 6.8% Higher
finance.yahoo.com - June 30 at 1:23 PM |
| Xeris Pharma prices stock and convertible debt offerings
seekingalpha.com - June 26 at 9:30 AM |
| Xeris Pharmaceuticals Announces Proposed Public Offerings of $20 Million of Common Stock and $60 Million of Convertible Senior Notes
finance.yahoo.com - June 24 at 5:36 PM |
| Xeris Pharma pramlintide-insulin candidate shows benefit in mid-stage study
seekingalpha.com - June 18 at 1:01 PM |
| Xeris Pharmaceuticals Announces Positive Topline Results from the Phase 2 Comparative Study of a Novel Pramlintide-insulin Co-formulation (XP-3924) in Adults with Type 1 Diabetes Mellitus
finance.yahoo.com - June 18 at 1:01 PM |
| Faruqi & Faruqi, LLP is Investigating Xeris Pharmaceuticals, Inc. (XERS) on Behalf of its Shareholders
finance.yahoo.com - June 15 at 12:28 PM |
 | Xeris Pharmaceuticals Announces Positive Results From the Outpatient Stage of a Phase 2 Study of Its Developmental Gvoke Ready-to-Use (RTU) Micro™ Glucagon in Adults at Risk ...
www.businesswire.com - June 15 at 7:27 AM |
| Xeris Pharmaceuticals Announces Positive Results From the Outpatient Stage of a Phase 2 Study of Its Developmental Gvoke Ready-to-Use (RTU) Micro™ Glucagon in Adults at Risk of Hypoglycemia During and After Aerobic Exercise
finance.yahoo.com - June 15 at 7:27 AM |
| Xeris Pharmaceuticals Announces Positive Findings From the Outpatient Portion of a Phase 2 Proof-of-Concept Study of Its Developmental Ready-to-Use (RTU) Glucagon in Patients ...
www.businesswire.com - May 22 at 12:47 PM |
| Xeris Pharmaceuticals Announces Positive Findings From the Outpatient Portion of a Phase 2 Proof-of-Concept Study of Its Developmental Ready-to-Use (RTU) Glucagon in Patients at Risk of Postprandial Hypoglycemia Following Bariatric Surgery
finance.yahoo.com - May 22 at 12:47 PM |
| The President of Xeris Pharmaceuticals, Inc. (NASDAQ:XERS), Paul Edick, Just Bought 32% More Shares
finance.yahoo.com - May 15 at 1:15 AM |
| Xeris Pharma inks distribution deal for Gvoke outside U.S.
seekingalpha.com - May 14 at 10:12 AM |
| Xeris Pharmaceuticals, Inc. (XERS) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 9 at 5:29 PM |
| Xeris Pharmaceuticals' (XERS) CEO Paul Edick on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 1:34 AM |
| NetworkNewsBreaks - Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) to Announce Q1 2020 Financial Results, Host Conference Call
www.marketwatch.com - May 7 at 5:10 PM |
| Xeris Pharmaceuticals EPS misses by $0.05, beats on revenue
seekingalpha.com - May 7 at 12:09 PM |
 | Xeris Pharmaceuticals: Q1 Earnings Insights
www.benzinga.com - May 7 at 12:09 PM |
 | Xeris' Shares March Higher, Can It Continue?
www.nasdaq.com - May 7 at 12:09 PM |
| Xeris' Shares March Higher, Can It Continue?
finance.yahoo.com - May 7 at 12:09 PM |
| Xeris Pharmaceuticals Inc (XERS) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 7 at 12:09 PM |
